# FY24 precisionFDA IDIQ 6 month Extension

Canonical: https://abierto.us/opportunities/75f40119d10041

- Solicitation number: 75F40119D10041
- Notice type: Special notice
- Status: Awarded to Dnanexus, Inc.
- Department: Department of Health and Human Services
- Agency: Food and Drug Administration
- Contracting office: FDA Office of Acq Grant SVCS (75F401)
- Place of performance: Rockville, Maryland
- County: Montgomery County (FIPS 24031). https://abierto.us/counties/montgomery-county-md-24031
- City: Rockville. https://abierto.us/cities/rockville-md-2467675
- First posted: September 16, 2024
- Last posted: September 30, 2024
- SAM.gov: https://sam.gov/workspace/contract/opp/a9ac2e1895a8401fb1f8b74320413200/view

## Description

This is a NOTICE OF INTENT to Award a Sole Source Modification for a Ceiling Increase under Contract 75F40119D10041. The Government intends to issue a sole source modification to FY24 precisionFDA IDIQ per Federal Acquisition Regulation 6.302-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements.

The modification will increase the ceiling of the existing Indefinite Delivery Indefinite Quantity (IDIQ) contract 75F40119D10041 from $20,000,000.00 to $23,036,960.56 to allow for a non-competitive, short-term, 6-month task order award in conjunction with raising the ceiling of the existing IDIQ. THIS NOTICE OF INTENT IS NOT A REQUEST FOR COMPETITIVE QUOTATIONS.

However, interested parties may identify their capability or address any inquiries by responding to the Contract Specialist prior to 3:00PM Eastern Standard Time, September 20, 2024, via email Allison.Meads@fda.hhs.gov. No reimbursement for any costs connected with providing capability information will be provided.

## Award on USAspending

- Recipient: Dnanexus, Inc. (UEI D3WLJYBFS2M3)
- Contract: 75F40119D10041
- Obligated: $0.00
- Competition: Full and Open Competition After Exclusion of Sources, 1 offers received
- Link: solicitation number 75F40119D10041 was reused as the contract number; same awarding office 75F401 (high confidence)
- Record: https://www.usaspending.gov/award/CONT_IDV_75F40119D10041_7524/


## Publications

- September 16, 2024: Special notice, due September 16, 2024 at 2:00 PM EDT. Notice 91a89235d6124b528e47b4d20e8e6a94. https://sam.gov/workspace/contract/opp/91a89235d6124b528e47b4d20e8e6a94/view
- September 30, 2024: Special notice, due September 16, 2024 at 2:00 PM EDT. Notice 8ce51781196b41c4b8c7895d4184ef5b. https://sam.gov/workspace/contract/opp/8ce51781196b41c4b8c7895d4184ef5b/view
- September 30, 2024: Special notice, due September 16, 2024 at 2:00 PM EDT. Notice a374c63cd8dc438d8b98d095ea4d2e18. https://sam.gov/workspace/contract/opp/a374c63cd8dc438d8b98d095ea4d2e18/view
- September 30, 2024: Special notice, due September 16, 2024 at 2:00 PM EDT. Notice a9ac2e1895a8401fb1f8b74320413200. https://sam.gov/workspace/contract/opp/a9ac2e1895a8401fb1f8b74320413200/view

## Points of contact

- Allison Meads, allison.meads@fda.hhs.gov

---
Source: SAM.gov Contract Opportunities bulk extract and USAspending.gov award data. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/75f40119d10041.